The Use of CAR-T Immunotherapy in the Treatment of Acute Lymphoblastic Leukemia: A Systematic Literature Review with Meta-Analysis
Future Pharmacology · 14.07.2026 · 6 (3) · 38
DOI: 10.3390/futurepharmacol6030038 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Future Pharmacology, online erschienen am 14.07.2026. Verfasst von Erica Eugênio Lourenço Gontijo und 17 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The objective of this study was to evaluate the efficacy and safety of CAR-T immunotherapy in inducing remission in patients with Acute Lymphoblastic Leukemia (ALL).
Methods
The search strategy was conducted in the BVS, Embase, PubMed, and ScienceDirect databases, where 4138 studies were initially identified.
Results
The final analysis resulted in the inclusion of 35 studies, all of which were incorporated into the meta-analysis, covering a cohort of 1313 patients. Statistical analysis was performed using R software (version 4.5.2), revealing a Complete Remission rate of 70.68% and a Minimal Residual Disease negativity rate of 76.68%. Tactical superiority was observed in the second-generation cells and in the dual CD19/CD22 target (82.20% CR). The risk of bias assessment using the ROBINS-I tool indicated high quality for most of the studies. The certainty of evidence according to the GRADE system was classified as moderate. Adverse events such as cytokine release syndrome (46.81%) and neurotoxicity (23.52%) were frequent but reversible.
Conclusions
We thus observe that CAR-T therapy is an effective strategic bridge to bone marrow transplantation, with advances in cell persistence being fundamental for sustained cure.
Zitieren
APA
Gontijo, E. E. L., Ferreira, R. G., Silveira, J. M. D., Minharro, S., Filho, S. C. C., Oliveira, M. F. A. D., Campos, F. S., Santos, G. R. D., Guimarães, A. L. S., Melo, J. L. T. D., Pinheiro, J. D., Eugênio, F., Borges, J. C. M., Neto, J. B., Chapla, V. M., Filho, R. N. D. A., Cunha, B. A. C. D., & Silva, M. G. D. (2026). The Use of CAR-T Immunotherapy in the Treatment of Acute Lymphoblastic Leukemia: A Systematic Literature Review with Meta-Analysis. Future Pharmacology, 6(3), 38. https://doi.org/10.3390/futurepharmacol6030038
Vancouver
Gontijo EEL, Ferreira RG, Silveira JMD, Minharro S, Filho SCC, Oliveira MFAD, et al. The Use of CAR-T Immunotherapy in the Treatment of Acute Lymphoblastic Leukemia: A Systematic Literature Review with Meta-Analysis. Future Pharmacology. 2026;6(3):38. doi:10.3390/futurepharmacol6030038
BibTeX
@article{Gontijo2026,
author = {Gontijo, Erica Eugênio Lourenço and Ferreira, Raphael Gomes and Silveira, Janne Marques da and Minharro, Silvia and Filho, Silvio Carneiro Cunha and Oliveira, Michell Frank Alves de and Campos, Fabricio Souza and Santos, Gil Rodrigues dos and Guimarães, Ana Luiza Silva and Melo, Júlia Lasmar Torquato de and Pinheiro, Julliana Dias and Eugênio, Frederico and Borges, Jaqueline Cibene Moreira and Neto, João Bartholomeu and Chapla, Vanessa Mara and Filho, Renisson Neponuceno de Araújo and Cunha, Benjamim Almeida Carneiro da and Silva, Marcos Gontijo da},
title = {The Use of CAR-T Immunotherapy in the Treatment of Acute Lymphoblastic Leukemia: A Systematic Literature Review with Meta-Analysis},
journal = {Future Pharmacology},
year = {2026},
volume = {6},
number = {3},
pages = {38},
doi = {10.3390/futurepharmacol6030038}
}
EUVIMED